Collectively, our data support the idea that, even in an immune-suppressive TME such as MM BM, highly activated NK cells could be triggered by TAC and could thereby serve as adjuvants of immune responses through the production of pro-inflammatory cytokines, such as IFN-γ. The gene discussed is IFNG; the disease is Miyoshi myopathy.